Product Information |
Product name | Liraglutide |
Sequence | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
CAS No. | 204656-20-2 |
Molecular Formula | C172H265N43O51 |
Molecular Weight | 3751.20 |
Storage | 2~8℃ |
Appearance | White to |
off-white crystalline powder |
COA of Liraglutide | Test | Specification |
Results | Appearance: | White to |
off-white crystalline powder or lumps | White powder | Identity: |
3751.2±1.0 | 3751.1 | Purity (By |
HPLC) : | Not Less than 98.0%; | 99.51% |
Residual | solvents: ≤0.25%total; | ≤0.1%individual; ≤0.01%CH2CN |
Complies | Related | Peptide |
Total Impurity | ≤ 2.0% | Largest Single |
Impurity ≤ 1.0% | TI =0.41% | LSI =0.25% |
Peptide | Content: | Not Less than |
85.0% |
87.7%
1、Water (K.F.):
Not more than
5%
4.2%
·Acetate acid:Not more than
· 10%8.1%
·Bacterial Endotoxins
·Not more than 50IU/mg
Complies
UsageFunction and Usage of Liraglutide 204656-20-2